LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 50.33 | 17.25 | 4 | 4651 | 0.0009 | -0.1656 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 50.33 | 17.25 | 1017 | 4651 | 0.2187 | 0.6568 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 52.30 | 17.25 | 830 | 4798 | 0.1730 | 0.6113 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 52.30 | 17.25 | 936 | 4798 | 0.1951 | 0.6353 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 52.30 | 17.25 | 1 | 4798 | 0.0002 | -0.2958 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 52.30 | 17.25 | 1038 | 4798 | 0.2163 | 0.6563 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 54.27 | 17.25 | 871 | 4884 | 0.1783 | 0.6185 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 54.27 | 17.25 | 937 | 4884 | 0.1919 | 0.6330 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 54.27 | 17.25 | 14 | 4884 | 0.0029 | -0.0253 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 54.27 | 17.25 | 1015 | 4884 | 0.2078 | 0.6492 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 56.24 | 17.25 | 908 | 4929 | 0.1842 | 0.6255 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 56.24 | 17.25 | 981 | 4929 | 0.1990 | 0.6410 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 56.24 | 17.25 | 2 | 4929 | 0.0004 | -0.2321 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 56.24 | 17.25 | 1075 | 4929 | 0.2181 | 0.6595 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.21 | 17.25 | 837 | 4942 | 0.1694 | 0.6090 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.21 | 17.25 | 913 | 4942 | 0.1847 | 0.6262 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.21 | 17.25 | 4 | 4942 | 0.0008 | -0.1640 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.21 | 17.25 | 1091 | 4942 | 0.2207 | 0.6621 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 60.18 | 17.25 | 975 | 5031 | 0.1938 | 0.6368 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 60.18 | 17.25 | 1045 | 5031 | 0.2077 | 0.6507 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 60.18 | 17.25 | 1 | 5031 | 0.0002 | -0.2938 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 60.18 | 17.25 | 1063 | 5031 | 0.2113 | 0.6541 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 63.15 | 17.25 | 982 | 5061 | 0.1940 | 0.6374 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 63.15 | 17.25 | 1073 | 5061 | 0.2120 | 0.6552 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 63.15 | 17.25 | 4 | 5061 | 0.0008 | -0.1633 | MN20160310_N02 | G16 |